Does size matter? Eminent professor, Lord Robert Winston, alongside two medtech giants, will offer opinions on company growth and the importance of size. From SME to global brands, are business development and innovation key to the success of all organisations? This is a great opportunity to network with the cream of the UK medical devices industry, to make new contacts and forge beneficial working relationships. Programme
Big, Bigger, Too Big? | | 10.00am - | Welcome and introduction
Tony Davis, CEO, Medilink West Midlands | | 10.40am - | Practical Growth from SME to Large Company
Philip Salt, CEO, Salts Healthcare
A look at the sustainable growth of Salts Healthcare, a 300 year old family company that has grown from a small enterprise to one of the UK’s leading manufacturers and suppliers if healthcare products | | 11.10am - | Taking Companies to the Next Level
John Jeans, President EMEA/AGM Life Sciences
Chairman GE Healthcare UK
How should companies position themselves in order to gain the commercial benefits from government initiatives and how to incorporate these initiatives into the company strategy? With particular reference to the work of the Ministerial Medical Technology Strategy Group | | 11.40am - | Tea & Coffee Break | | 12.00pm - | Prof Lord Robert Winston
Can a company become too large? Is there a risk of becoming insular and stuck in your ways? This talk will look at how companies can use medical science and technology to regenerate. | | 13.15pm - | Editors Lunch
Featuring:
Ashley Yeo, Editor, Clinica
Gay Sutton, Editor, Manufacturer
Coralie Palmer. Editor, Medilink UK Review | | 14.15pm - | Networking Session
An afternoon of structured networking using the proven ‘dance card’ system. This is a unique opportunity to meet with the cream of the UK medical device technology industry, to forge new business contact and beneficial relationships. | | 16.30pm - | Close |
SPEAKERS
| Philip Salt, CEO, Salts Healthcare | |  Philip Salt is Chief Executive of Salts Healthcare Ltd. Salts is a family owned business established in 1701 and Philip belongs to the 10th generation of the family which has lead the Company for over 300 years. It is believed to be the oldest family run business in the country.
Salts core business is in stoma care. It also has a wound care division and has recently launched Techstep, a modernised orthotic business.
Philip has overseen a growth in the business in the UK and overseas which has been based on investment in innovation looking after the customer.
He served on the original Department of Health: Healthcare Industries Task Force (HITF) and is passionate about innovation in all its forms. Philip is a past Chairman of the British Healthcare Trades Association (BHTA) and is current Chairman of the Stoma and Continence Manufacturers Section. He also chairs the Drug Tariff Industry Forum, the negotiating body which deals with the PPD.
Philip is a family man and keen sportsman who still plays rugby. He loves to be on the water and last year was one of the few finishers of the famously stormy 2007 Fastnet race. |
| John Jeans, Vice-President International, Life Sciences and Chairman UK GE Healthcare |  John Jeans has a broad background in the International Healthcare industry working for a number of companies including Smith & Nephew, BMS, Johnson & Johnson and Amersham plc (now GE Healthcare), spanning more than 35 years. His experience ranges from medical devices and pharmaceuticals to in-vivo and in-vitro diagnostics encompassing research, product development, manufacturing and commercialisation.
He is currently President of GE Healthcare Life Sciences’ commercial operations in Europe and Asia, and is Chairman of GE Healthcare Ltd.
An active participant in industry associations, John has held executive posts in both BIVDA (British In Vitro Diagnostic Association), EDMA (European Diagnostic Manufacturers Association) and is a past President of AIPES (Association of Imaging Producers and Equipment Suppliers). He has also been an editorial contributor to the European Journal of Nuclear Medicine on industry matters and sits on various Government and Clinical, including the Co-Chairmanship of a Ministerial Committee on Medical Technologies. |
| Prof Lord Robert Winston |  Robert Winston, Emeritus Professor of Fertility Studies at Imperial College, believes that public engagement with science is vital. Scientific knowledge has huge promise but its possible misuse means that it is important that society has adequate control of what is done in its name. Robert Winston's own research area is a good example of both promise and threat. He is exploring innovative ways of introducing new genes into cells, particularly stem cells. Stem cells are "parent" cells capable of turning into one of the many different types of cell in the human body. When genetically modified they could be used to provide tissues and organs for human transplantation for some of the numerous serious degenerative diseases so common in humans. But misuse of this technology is also potentially dangerous. Used in human reproduction, genetic manipulation of this kind might eventually be employed to modify or enhance human characteristics - hence changing the whole nature of our society. Professor Winston has an international reputation for his researches into human reproduction and has pioneered advances widely used in fertility and IVF treatment. Amongst the public, he is perhaps best known for his work in popularising science. Broadcasting regularly, he has made many highly successful television series on science and medicine, written a number of popular science books for both adults and children, and is a sought-after speaker to adult audiences, and to children in schools. As a member of the House of Lords he regularly speaks in parliament on science, medicine, education and the arts. As well as his research at Imperial College London, he is Chairman of the Royal College of Music and Chancellor of Sheffield Hallam University. |
TO BOOK YOUR PLACE SIMPLY CLICK HERE AND
COMPLETE THE ONLINE BOOKING FORM |
A Medilink West Midlands event in association with Medilink UK, BIVDA & GAMBICA |
